News

An independent monitoring board recommended early termination of the PALM trial after determining that 2 of the 4 experimental therapies were linked with better rates of survival.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of August 4, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The Florida Department of Health has confirmed that a locally-acquired case of dengue has been documented in Miami-Dade County.

A UK study details a new way to prevent Legionnaires' disease and save energy.

From January 2019 to July 20, 2019, the Philippines has recorded 146,062 cases of dengue and 622 deaths, a 98% increase from the same period in 2018.

Blocking the transport of critical metals like zinc into the cell could be a way to prevent growth and therefore infection by Neisseria gonorrhoeae.

The committee voted 16 to 2 to recommend F/TAF for PrEP based upon data from the phase 3 DISCOVER study, which evaluated F/TAF in comparison with F/TDF.

The Ad26.ZEBOV, MVA-BN-Filo vaccine regimen will be evaluated in an open-label, single-arm study of 800 participants, including frontline health care workers.

Investigators exposed 6 genetically distinct, clinically relevant methicillin-resistant S aureus isolates to cigarette smoke to analyze how this contact altered specific virulence phenotypes.

An analysis of existing studies suggests prevalence of non-physician-sanctioned administration may be as high as 66%.

A study found no significant difference in outcomes between ceftazidime, carbapenems, and piperacillin-tazobactam as monotherapy for treating P aeruginosa, offering insight that may help antibiotic stewardship programs.

A pair of new studies is raising concern that standard malaria therapies may no longer work for large portions of the world’s malaria cases.

A new study sheds light on how sustainable efforts can be made to improve hand hygiene.

The state has documented 2582 cases of hepatitis A in the ongoing outbreak. Health officials indicate that 98% of those cases were acquired within the state.

Some rural counties with historically low rates of HIV infection are now experiencing increased risks for HIV transmission of the virus and do not have the infrastructure or resources to respond appropriately.

Investigators say that 12 weeks following vaccination neutralizing antibodies remained 5- to 10-fold above baseline levels in all vaccine dosage groups.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 28, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The first step (prime) is to immunize with conventional vaccines through a needle in the arm. The second step (pull), is to apply an antibiotic cream that helps attract, T cells, to the site of virus growth.

The latest guidance on preparing for and responding to measles in your health care facility.

When speaking with patients or parents, it is important for health care practitioners to stress that vaccines are safe, and vaccines save lives.

Initiating and adhering to ART is a difficult task for a significant number of people living with HIV. A new study shows that making a concerted effort to find and encourage this population to get the care they need is not an impossible dream.

Efforts to understand the rare polio-like condition acute flaccid myelitis got a boost from the NIAID, which awarded $10 million over 5 years for a natural history study.

The new recommendations aim to limit the potentially deadly disease from infecting newborns or mothers.

August 1, 2019, marks the 1 year anniversary of the North Kivu Ebola outbreak.

As July draws to a close, the Contagion® editorial team is recapping the trends and top infectious disease news of the month.

The adjusted hazard ratios for 1-dose and 2-dose recipients were comparable to the 3-dose recipients (1 dose 1.01 [95%CI 0.81–1.26], 2 doses 1.00 [0.85–1.17]) after adjusting for age at vaccination among the vaccinated group.